MarTide, the new weight loss drug from Amgen, works. Not just well enough for Wall Street. Shares of the Thousand Oaks-based biotech giant fell 10% on Nov. 26 after it announced that MarTide's latest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback